Novo Nordisk A/S expects to elect new chairman in 2013
Posted: 27 April 2012 | | No comments yet
Sten Scheibye has been elected to the Board of the Novo Nordisk Foundation…
In a press release today, the Novo Nordisk Foundation announced that the current chairman of the Board of Novo Nordisk A/S, Sten Scheibye, has been elected to the Board of the Novo Nordisk Foundation with a view to becoming its chairman in 2013.
Sten Scheibye has informed the Board of Novo Nordisk A/S that in light of this he expects to step down from the company’s Board at the annual general meeting in March 2013.
The Board expects to propose Göran Ando, currently the vice chairman of the Board, as chairman in 2013, and will announce its proposal for new vice chairman next year prior to the annual general meeting.
As member of the Board of the Novo Nordisk Foundation, Sten Scheibye is now regarded as non-independent director in the Board of Novo Nordisk A/S. With this change, four out of the eight Board members elected by general meeting are regarded as independent.
Sten Scheibye was first elected to the Board of Novo Nordisk A/S in 2003. He became vice chairman in 2004 and chairman in 2006.
Says Sten Scheibye: “I am very pleased that Göran Ando is prepared to take over the chair in 2013 and thereby ensure a smooth transition. He has been on the board for more than seven years, the last six as vice chairman, and he has impressed all of us with his expertise and insights.”